期刊文献+

Elevated serum values of procollagen Ⅲ peptide (PIIIP)in patients with ulcerative colitis who will develop pseudopolyps 被引量:2

Elevated serum values of procollagen Ⅲ peptide (PIIIP)in patients with ulcerative colitis who will develop pseudopolyps
下载PDF
导出
摘要 AIM: To assess the impact of procollagen Ⅲ peptide as a marker of collagenesis in the development of pseudopolyps in patients with ulcerative colitis.METHODS: Development of pseudopolyps was monitored in 25 patients with ulcerative colitis classified according to Powell-Tuck index as mild (n=12) or moderate (n=13) form of disease. Patients with a mild form of disease were treated with oral mesalazine medication (2-4 g/day) and local mesalazine preparation (suppository). Patients with a moderate form of disease received oral mesalazine medication (2-4 g/day), local mesalazine preparation(suppository) and local methylprednisolone at an initial dose of 60 rag/day, followed by dose tapering. How many significant variables (previously determined by analysis of variance) were elevated in the groups with and without pseudopolyp developement was observed. ROC analysis for calculation of new index was made.RESULTS: Serum values of procollagen Ⅲ peptide (PⅢP), C-reactive protein (CRP) and C4 complement component (C4)were statistically significantly lower in the group of patients flee from pseudopolyp development bhan bhose who developed one or more pseudopolyps (0.45±0.12 vs 1.42±0.70,P<0.0027; 7.6±4.7 vs 17.8±9.17, P<0.035, and 0.46±0.11 vs 0.34±0.16, P<0.068, respectively) at endoscopic conrtrols with patohistologically samples during 13 months. There were no statistically significant differences in the values of C3, ceruloplasmin and IgM between the two groups (P>0.05).Discrimination function analysis yielded highest standardized cannon coefficients for PⅢP (0.876), CRP (0.104), C3 (-0.534) and C4 (0.184) (P<0.036). The elevation in two of three laboratory variables (PⅢP, CRP and C4) reached sensitivity of 93 % and specificity of 90 % in the development of pseudopolyps.CONCLUSION: It is proposed that an increase in two of the three laboratory parameters (PⅢP, CRP and C4) could improve the accuracy of prediction of the development of pseudopolyps. When using PⅢP, CRP and C4 on decision making, the positive predictive value and accuracy were 90 % and 92 %, respectively. AIM;To assess the impact of procollagen Ⅲ peptide as a marker of collagenesis in the development of pseudopolyps in patients with ulcerative colitis. METHODS:Development of pseudopolyps was monitored in 25 patients with ulcerative colitis classified according to Powell-Tuck index as mild(n=12)or moderate(n=13)form of disease.Patients with a mild form of disease were treated. with oral mesalazine medication(2-4 g/day)and local mesalazine preparation(suppository).Patients with a moderate form of disease received oral mesalazine medication(2-4 g/day),local mesalazine preparation (suppository)and local methylprednisolone at an initial dose of 60 mg/day,followed by dose tapering.How many significant variables(previously determined by analysis of variance)were elevated in the groups with and without pseudopolyp developement was observed.ROC analysis for calculation of new index was made. RESULTS:Serum values of procollagen Ⅲ peptide(PⅢP),C- reactive protein(CRP)and C4 complement component(C4) were statistically significantly lower in the group of patients free from pseudopolyp development than those who developed one or more pseudopolyps(0.45±0.12 vs 1.42±0.70, P<0.0027;7.6±4.7 vs 17.8±9.17,P<0.035;and 0.46±0.11 vs0.34±0.16,P<0.068,respectively)at endoscopic conrtrols with patohistologically samples during 13 months.There were no statistically significant differences in the values of C3,ceruloplasmin and IgM between the two groups(P>0.05). Discrimination function analysis yielded highest standardized cannon coefficients for PⅢP(0.876),CRP(0.104),C3(-0.534) and C4(0.184)(P<0.036).The elevation in two of three laboratory variables(PⅢP,CRP and C4)reached sensitivity of 93 % and specificity of 90 % in the development of pseudopolyps. CONCLUSION:It is proposed that an increase in two of the three laboratory parameters(PⅢP,CRP and C4)could improve the accuracy of prediction of the development of pseudopolyps.When using PⅢP,CRP and C4 on decision making,the positive predictive value and accuracy were 90 % and 92 %,respectively.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第3期619-621,共3页 世界胃肠病学杂志(英文版)
  • 相关文献

同被引文献16

  • 1Zhu, Chang-Tai,Dong, Chun-Lei.Characteristics of general distribution of hepatitis B virus genotypes in China[J].Hepatobiliary & Pancreatic Diseases International,2009,8(4):397-401. 被引量:32
  • 2雷延昌,郝友华,田拥军,孟忠吉,王宝菊,田德英,赵西平,杨东亮.湖北地区乙型肝炎病毒基因型分布与临床的相关性[J].中华肝脏病杂志,2005,13(2):109-112. 被引量:52
  • 3余文辉,周小梅,周大桥,李顺民,贺劲松,李爱娣.锁核酸捕获TaqMan探针实时PCR和PCR-RFLP检测乙型肝炎病毒基因变异的研究[J].中华微生物学和免疫学杂志,2007,27(11):977-982. 被引量:9
  • 4Hou J,Liu Z,Gu F.Epidemiology and prevention of hepatitisB virus infection[].Int J Med Sci.2005
  • 5Sugauchi F,Orito E,Ichida T,et al.Hepatitis B virus ofgenotype B with or without recombination with genotype C o-ver the precore region plus the core gene[].Journal of Virology.2002
  • 6Morozov V,Pisareva M,Groudinin M.Homologous recombi-nation between different genotypes of hepatitis B virus[].Gene.2000
  • 7Kao JH,Chen PJ,Lai MY,et al.Hepatitis B genotypes cor-relate with clinical outcomes in patients with chronic hepatitisB[].Gastroenterology.2000
  • 8Zeng G,Wen S,Wang Z,et al.Geographic distribution,clin-ical outcomes and virological characteristics of hepatitis B virusgenotypes in China[].Journal of Viral Hepatitis.2005
  • 9Chien RN,Yeh CT,Tsai SL,et al.Determinant for sus-tained HBeAg response to lamivudine therapy[].Hepatology.2003
  • 10Chu CJ,Hussain M,Lok AS.Hepatitis B virus genotype B isassociated with earlier HBeAg seroconversion compared withhepatitis B virus genotype C[].Gastroenterology.2002

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部